FINWIRES · TerminalLIVE
FINWIRES

インペリアル・オイルの第1四半期純利益は前年同期比で減少

By

-- インペリアル・オイル(IMO.TO)は金曜日、第1四半期の純利益が前年同期比で減少したと発表した。 インペリアル・オイルの純利益は9億4000万カナダドル(1株当たり1.94米ドル)で、前年同期の12億9000万カナダドル(1株当たり2.52米ドル)から減少した。 ファクトセットによると、アナリストはインペリアル・オイルの1株当たり利益を2.30米ドルと予想していた。 売上高は124億5000万カナダドル(前年同期は125億2000万カナダドル)に減少した一方、費用は112億1000万カナダドル(前年同期は108億3000万カナダドル)に増加した。 上流部門の生産量は、第1四半期に日量41万9000バレル(石油換算)となり、前年同期の日量41万8000バレル(石油換算)から増加した。 「世界的な商品市場の著しい変動を背景に、当社は既存資産の価値を最大化しつつ、優位な成長機会を追求するという長年の企業戦略に引き続き注力してまいります」と、会長兼社長兼最高経営責任者(CEO)のジョン・ウィーラン氏は述べました。 インペリアル・オイルは、第2四半期の配当を1株当たり0.87ドルと発表しました。これは第1四半期と同額です。配当金は7月1日に、6月4日現在の株主名簿に記載されている株主に対して支払われます。 同社は6月に通常の自己株式取得プログラム(IPO)を再開する予定です。

Related Articles

Research

Research Alert: Dino: Q1 Refining Margin Strength

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:DINO delivered exceptional Q1 results with adjusted EPS of $0.69 vs. a consensus loss of $0.27, beating by $0.74, while adjusted EBITDA more than doubled to $426M from $201M. The refining segment led the recovery with $514M operating income vs. a$30M loss in the prior year, though regional performance diverged with West margins expanding to $14.61/barrel while Mid-Continent compressed to $3.58/barrel. We believe the strong performance reflects improving refining fundamentals and regulatory tailwinds in renewables. The renewables segment returned to profitability with $182M operating income, benefiting from higher volumes, improved margins, and $49M in prior-year Producer Tax Credit benefits. Cash generation remained robust at $457M from operations, more than covering $167M in shareholder returns, while the balance sheet strengthened with cash rising to $1.15B. We expect continued benefit from favorable renewable diesel demand dynamics and small refinery RINs waivers.

$DINO
Research

Research Alert: CFRA Reiterates Hold Opinion On Shares Of Iex

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $235 from $220 following Q1, valuing shares at 26x our 2027 EPS outlook of $9.04 (up from $8.99; 2026 EPS view revised to $8.50 from $8.28). IEX posted a robust Q1, with operating EPS of $2.00 rising 14% Y/Y and exceeding consensus by $0.23, propelled by standout performance in Health & Science Tech. Organic sales growth accelerated to 5% Y/Y from 1% in Q4, while orders hit a record $988M (up 10% Y/Y), signaling broadened demand. Health & Science Tech was the clear growth engine, delivering 11% organic sales growth alongside 100-bp adjusted EBITDA margin expansion to 26.6%. This strength was fueled by AI-driven demand for data center power solutions, semiconductor applications, and space & defense markets. Despite gross margin compression of 40 bps, adjusted EBITDA margin expanded 50 bps to 26%, suggesting the company's 80/20 initiatives are gaining traction.Overall, Q1 results were encouraging and contributed to our raised growth outlook for the year.

$IEX
Australia

Oppenheimer Adjusts Price Target on Twilio to $200 From $170, Maintains Outperform Rating

Twilio (TWLO) has an average rating of overweight and mean price target of $185.40, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $172.10, Change: $+24.04, Percent Change: +16.24%

$TWLO